Patent Assignment
Reel/Frame 026371/0651
Change of Name
Recorded: 2011-06-01
Pages: 3
Assignor
IDEC PHARMACEUTICALS CORPORATION
Executed: 2003-11-12
Assignee
BIOGEN IDEC INC.
14 CAMBRIDGE CENTER, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties
(3)
Treatment of Aggressive Non-Hodgkins Lymphoma with Anti-CD20 Antibody
Patent:
8,557,244 →
Application:
09/628,187 →
Combination Therapies for B-Cell Lymphomas Comprising Administration of Anti-CD20 Antibody
Use of Chimeric Anti-CD20 Antibody as in Vitro or in Vivo Purging Agent in Patients Receiving Bmt or Pbsc Transplant
Application:
13/051,054 →
Publication:
US 2011/0165159
Related Assignments
(2)
Other recorded transfers of the patents in this record — the chain of ownership.